Cargando…
Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report
BACKGROUND: Pneumatosis intestinalis is a rare adverse event that occurs in patients with lung cancer, especially those undergoing treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). Osimertinib is the most recently approved EGFR-TKI, and its usage is increasing in...
Autores principales: | Nukii, Yuki, Miyamoto, Atsushi, Mochizuki, Sayaka, Moriguchi, Shuhei, Takahashi, Yui, Ogawa, Kazumasa, Murase, Kyoko, Hanada, Shigeo, Uruga, Hironori, Takaya, Hisashi, Morokawa, Nasa, Kishi, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394003/ https://www.ncbi.nlm.nih.gov/pubmed/30819142 http://dx.doi.org/10.1186/s12885-019-5399-5 |
Ejemplares similares
-
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
por: Uruga, Hironori, et al.
Publicado: (2018) -
The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis
por: Ogawa, Kazumasa, et al.
Publicado: (2018) -
Clinicoradiological Features of Pulmonary Tuberculosis with Interstitial Pneumonia
por: Ogawa, Kazumasa, et al.
Publicado: (2019) -
Various Bronchiolar Lesions Accompanied by Idiopathic Pleuroparenchymal Fibroelastosis with a Usual Interstitial Pneumonia Pattern Demonstrating Acute Exacerbation
por: Miyamoto, Atsushi, et al.
Publicado: (2018) -
Transformation of epidermal growth factor receptor T790M mutation‐positive adenosquamous carcinoma of the lung to small cell carcinoma and large‐cell neuroendocrine carcinoma following osimertinib therapy: an autopsy case report
por: Moriguchi, Shuhei, et al.
Publicado: (2019)